A First in Human Study to Assess the Safety, Tolerability and Immunogenicity of a Single Dose of a Trivalent Inactivated Poliovirus Vaccine Based on Sabin Strains (sIPV) Given Intramuscularly in Healthy Adults
Clinical trial NCT03032588 · COMPLETED
Trial details
- NCT number
- NCT03032588
- Sponsor
- Janssen Vaccines & Prevention B.V.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-09
- Primary completion
- 2018-05-18
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.